Profile data is unavailable for this security.
About the company
ReNeuron Group plc is a United Kingdom-based Stem Cell and Exosome Technologies company that utilizes its stem cell technologies to develop treatments for disease with unmet needs. The Company’s stem cell derived Exosome Technology platform offers a delivery mechanism for a variety of payloads, such as small interfering Ribonucleic Acid (siRNA), messenger RNA (mRNA), proteins, small molecules and genes. The Company has two clinical-stage stem cell therapy candidate assets, a Phase 2a human retinal progenitor cell (hRPC) therapy candidate in retinitis pigmentosa and a Phase 2b immortalized neural progenitor cell therapy candidate (CTX) in stroke. The Company through its induced pluripotent stem cell (iPSC) platform has the ability to make allogeneic tissue cells of choice and has the potential to produce exosomes with tissue specific targeting ability.
- Revenue in GBP (TTM)274.00k
- Net income in GBP-9.49m
- Incorporated2005
- Employees43.00
- LocationReNeuron Group PLCPencoed Business ParkBRIDGEND CF35 5HYUnited KingdomGBR
- Phone+44 203 819 8400
- Fax+44 148 353 4864
- Websitehttp://www.reneuron.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parity Group plc | 4.08m | -636.00k | 8.63m | 35.00 | -- | 1.23 | -- | 2.12 | -0.0062 | -0.0062 | 0.0397 | 0.0682 | 0.2888 | -- | 0.7535 | 116,571.40 | -4.50 | 0.4326 | -9.17 | 1.11 | -- | -- | -15.59 | 0.2286 | -- | -3.84 | 0.2663 | 0.00 | -26.63 | -46.35 | -35.32 | -- | -10.86 | -- |
| Aquila Services Group PLC | 8.99m | 260.00k | 10.39m | 76.00 | 41.14 | 1.77 | 27.34 | 1.16 | 0.0063 | 0.0063 | 0.2209 | 0.1469 | 1.15 | -- | 4.10 | 118,263.20 | 3.33 | 5.38 | 4.29 | 7.28 | 22.66 | 23.64 | 2.89 | 4.52 | -- | -- | 0.0526 | 74.00 | -4.03 | 10.00 | 48.41 | -- | -15.59 | -3.58 |
| ValiRx Plc | 0.00 | -1.52m | 10.90m | 7.00 | -- | 3.03 | -- | -- | -0.0234 | -0.0234 | 0.00 | 0.0553 | 0.00 | -- | -- | 0.00 | -36.57 | -58.96 | -35.94 | -77.90 | -- | -- | -- | -- | -- | -605.72 | 0.0169 | -- | -- | -- | -5.19 | -- | -- | -- |
| React Group PLC | 7.70m | 389.00k | 11.28m | 28.00 | 15.81 | 1.96 | 17.28 | 1.47 | 0.0007 | 0.0007 | 0.0136 | 0.0055 | 1.64 | -- | 4.83 | -- | 8.29 | -13.52 | 13.61 | -19.17 | 30.76 | 29.50 | 5.05 | -9.14 | 1.00 | -- | 0.0356 | -- | 76.63 | 25.93 | 106.91 | -- | -19.50 | -- |
| Bivictrix Therapeutics PLC | 0.00 | -2.34m | 13.22m | 5.00 | -- | 2.09 | -- | -- | -0.1694 | -0.1694 | 0.00 | 0.0957 | 0.00 | -- | -- | 0.00 | -58.88 | -- | -64.64 | -- | -- | -- | -- | -- | -- | -2.34 | 0.0374 | -- | -- | -- | -450.59 | -- | -- | -- |
| Afriag Global PLC | 0.00 | -2.16m | 13.47m | 18.00 | -- | 0.8236 | -- | -- | -0.0665 | -0.0665 | 0.00 | 0.0219 | 0.00 | -- | -- | -- | -82.61 | -21.17 | -126.34 | -30.96 | -- | 7.04 | -- | -25.49 | -- | -7.12 | 0.00 | -- | -100.00 | -- | -586.16 | -- | -- | -- |
| All Things Considered Group PLC | 11.13m | -1.95m | 14.57m | 17.00 | -- | -- | -- | 1.31 | -0.2038 | -0.2038 | 1.16 | -0.2442 | 2.49 | -- | 5.84 | 654,821.80 | -64.96 | -- | -512.72 | -- | -1.80 | -- | -26.07 | -- | -- | -10.01 | -- | -- | 127.06 | -- | 31.23 | -- | -- | -- |
| Silver Bullet Data Services Group Ltd | 3.81m | -8.51m | 15.03m | 62.00 | -- | 1.38 | -- | 3.94 | -0.6342 | -0.6342 | 0.2839 | 0.6878 | -- | -- | -- | -- | -- | -- | -- | -- | 73.11 | -- | -223.42 | -- | -- | -406.12 | 0.017 | -- | 36.58 | -- | -66.28 | -- | -- | -- |
| One Media IP Group PLC | 4.39m | 544.58k | 15.24m | 11.00 | 30.18 | 1.03 | 12.76 | 3.47 | 0.0023 | 0.0023 | 0.0164 | 0.0664 | 0.2548 | -- | 3.35 | 399,052.70 | 3.16 | 4.40 | 3.36 | 4.77 | 74.91 | 55.53 | 12.41 | 13.60 | -- | 4.59 | 0.1058 | -- | 9.59 | 16.50 | -13.59 | 54.00 | 79.06 | -4.98 |
| NAHL Group PLC | 38.95m | 156.00k | 16.12m | 259.00 | 103.26 | 0.2847 | 3.05 | 0.4139 | 0.0034 | 0.0034 | 0.8422 | 1.22 | 0.3915 | -- | 1.59 | 150,374.50 | 3.63 | 5.67 | 4.62 | 7.08 | 45.18 | 48.16 | 9.26 | 11.87 | -- | 8.84 | 0.262 | 93.43 | -4.72 | -4.64 | 169.33 | -58.20 | -0.1605 | -- |
| ReNeuron Group Plc | 274.00k | -9.49m | 16.26m | 43.00 | -- | 1.15 | -- | 59.35 | -0.1854 | -0.1854 | 0.0054 | 0.2486 | 0.0149 | -- | 0.4053 | 6,372.09 | -51.51 | -34.68 | -86.63 | -40.80 | -- | -- | -3,463.14 | -1,088.16 | -- | -68.98 | 0.0429 | -- | -95.76 | 54.71 | 0.5696 | -- | -38.88 | -- |
| ImmuPharma PLC | 118.35k | -8.17m | 17.78m | 14.00 | -- | 4.03 | -- | 150.26 | -0.0325 | -0.0325 | 0.0005 | 0.0155 | 0.014 | -- | 0.4017 | 8,453.57 | -96.66 | -94.13 | -116.20 | -109.64 | -- | -- | -6,906.55 | -6,235.41 | -- | -2.19 | 0.0002 | -- | -6.57 | -6.40 | -19.15 | -- | 60.85 | -- |
| Gattaca PLC | 411.39m | -701.00k | 19.54m | 540.00 | -- | 0.6231 | 8.63 | 0.0475 | -0.0219 | -0.0782 | 12.71 | 0.971 | 4.61 | -- | 8.09 | 851,741.20 | -0.7856 | -2.23 | -1.81 | -4.28 | 10.35 | 10.76 | -0.1704 | -0.5376 | -- | 3.20 | 0.3055 | -- | -22.25 | -7.61 | 146.08 | -29.00 | 18.76 | -42.07 |
| National Milk Records Plc | 22.58m | 2.36m | 21.13m | 276.00 | 8.95 | 2.95 | 6.53 | 0.936 | 0.1112 | 0.1112 | 1.06 | 0.3375 | 1.78 | 22.88 | 6.13 | 81,804.35 | 18.65 | -- | 27.74 | -- | 42.79 | -- | 10.46 | -- | 1.41 | -- | 0.2209 | -- | 1.51 | -- | 102.78 | -- | -- | -- |
| Skillcast Group PLC | 8.41m | 377.63k | 21.47m | 86.00 | 52.06 | 2.97 | 32.51 | 2.55 | 0.0046 | 0.0046 | 0.1036 | 0.0807 | -- | -- | -- | 97,768.14 | -- | -- | -- | -- | 70.54 | -- | 4.49 | -- | -- | -35.61 | 0.0818 | -- | 15.29 | -- | -58.23 | -- | -- | -- |
| Deepverge PLC | 6.80m | -4.23m | 22.52m | 9.00 | -- | 0.8716 | -- | 3.31 | -0.0256 | -0.0256 | 0.0414 | 0.1176 | 0.3371 | 3.77 | 4.12 | -- | -20.99 | -43.87 | -24.27 | -66.66 | 43.70 | 45.96 | -62.27 | -222.57 | 2.36 | -8.07 | 0.1056 | -- | 444.71 | 306.88 | -19.68 | -- | 10.16 | -- |
Data as of Jun 27 2022. Currency figures normalised to ReNeuron Group PLC's reporting currency: UK Pound GBX
38.90%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Hargreaves Lansdown Stockbrokers Ltd.as of 02 May 2022 | 4.32m | 7.57% |
| Jarvis Investment Management Ltd.as of 02 May 2022 | 3.62m | 6.34% |
| Octopus Investments Ltd.as of 04 Jun 2021 | 3.35m | 5.87% |
| Schroder Investment Management Ltd.as of 12 Mar 2021 | 2.84m | 4.97% |
| Woodford Investment Management Ltd.as of 02 May 2022 | 2.43m | 4.25% |
| Hargreaves Lansdown Asset Management Ltd.as of 02 May 2022 | 2.41m | 4.23% |
| Walker Crips Investment Management Ltd.as of 02 May 2022 | 1.18m | 2.07% |
| KW Investment Management Ltd.as of 02 May 2022 | 755.00k | 1.32% |
| IG Markets Ltd.as of 02 May 2022 | 671.00k | 1.18% |
| Smith & Williamson Investment Management LLPas of 02 May 2022 | 630.00k | 1.10% |
More ▼
Data from 31 Mar 2022 - 02 Jun 2022Source: FactSet Research Systems Inc.
